Skip to main content
Premium Trial:

Request an Annual Quote

Cell Projects, Queen's University to Develop Electroporation Technologies

NEW YORK (GenomeWeb News) – Cell Projects has signed a licensing and joint development agreement with Queen’s University in Ontario, Canada, to develop new electroporation technologies for adherent and in situ cell electroporation.
 
According to a statement released yesterday by Maidstone, UK-based Cell Projects, the new technology allows DNA, peptides, siRNA, and other molecules to be transported into cultured, adherent cells while the cells are still attached to their growing surface.
 
The technology “will enable a greater understanding of specific cellular activities that to date have been difficult to analyze yet are known to be important in further understanding the mechanism of cancer, and other biological problems,” said Tom Hole, managing director of Cell Projects.
 
Financial terms of the alliance were not disclosed.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.